Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager

Published:2017-05-16 Issue:32 Volume:8 Page:52866-52876
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bi Yanyu¹,Jiang Hua¹,Wang Peng²,Song Bo²,Wang Huamao²,Kong Xianming³,Li Zonghai¹²

Affiliation:

1. State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

2. CARsgen Therapeutics, Shanghai, China

3. Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric MRI combined with clinical factors to predict glypican-3 expression of hepatocellular carcinoma;Frontiers in Oncology;2023-11-09

2. Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy;Journal of Controlled Release;2023-08

3. Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors;Cancers;2022-10-18

4. Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report;Frontiers in Immunology;2022-08-17

5. Advances in CAR-T cell therapy for malignant solid tumors;Journal of Zhejiang University (Medical Sciences);2022-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP